Target intelligence / Profile preview

Leishmania mitochondrial 30S ribosomal subunit (30S mitoribosomal subunit)

Target
30S mitoribosomal subunit
Molecular classification
Ribonucleoprotein complex, Ribosome
01

Overview

The 30S ribosomal subunit in Leishmania parasites is the smaller component of the mitochondrial ribosome (mitoribosome), which is distinct from the cytosolic 40S subunit. In kinetoplastid parasites like Leishmania, the mitoribosome is uniquely structured, consisting of a 30S small subunit and a 40S large subunit, which together form a 50S complex responsible for translating essential mitochondrial-encoded proteins. This subunit is a critical therapeutic target because it contains highly conserved regions, such as the aminoacyl-tRNA binding site (A-site), which are susceptible to aminoglycoside antibiotics. Drugs like paromomycin bind to this subunit, disrupting the fidelity of translation and leading to parasite cell death. Because of the structural differences between the Leishmania mitoribosome and the human mitoribosome, it offers a window for selective toxicity, although high doses can still lead to adverse effects in the host.

Other names
Small mitoribosomal subunitLeishmania 30S subunitMitochondrial SSUKinetoplastid 30S ribosomal subunit
02

Mechanism of action

Inhibition of protein synthesis by binding to the decoding site (A-site) of the small ribosomal subunit, inducing mRNA misreading and premature termination of translation.

03

Biological functions

Protein synthesisMitochondrial translationDecoding of mRNA
04

Disease associations

InfectionLeishmaniasis (Visceral, Cutaneous, and Mucocutaneous)
05

Safety considerations

OtotoxicityNephrotoxicityPotential cross-reactivity with host mitochondrial ribosomesDevelopment of drug resistance
06

Interacting drugs

Paromomycin

3 more in the full profile.

07

Biomarkers

Mitochondrial membrane potential (as a proxy for mitochondrial health)Parasite load (qPCR)Ribosomal RNA (rRNA) sequence analysis for resistance mutations

Beyond the preview

Go deeper on Leishmania mitochondrial 30S ribosomal subunit (30S mitoribosomal subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leishmania mitochondrial 30S ribosomal subunit (30S mitoribosomal subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call